Generation of a MLL-AF9-specific stem cell model of acute monocytic leukemia

References

• Hu J, Hong X, Li Z. et al Acute monocytic leukaemia with t(11; 12) (p15; q13) chromosomal changes: a case report and literature review. Oncol Lett. 2015;10:2307–2310.
   PubMed Web of Science ®Google Scholar
• Tallman MS, Kim HT, Paietta E, et al. Acute monocytic leukemia (French-American-British classification M5) does not have a worse prognosis than other subtypes of acute myeloid leukemia: a report from the Eastern cooperative oncology group. J Clin Oncol. 2004;22:1276–1286.
   PubMed Web of Science ®Google Scholar
• Yan XJ, Xu J, Gu ZH, et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet. 2011;34:309–317.
   Web of Science ®Google Scholar
• Corral J, Lavenir I, Impey H, et al. An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: a method to create fusion oncogenes. Cell. 1996;85:853–861.
   PubMed Web of Science ®Google Scholar
• Fleischmann KK, Pagel P, Schmid I, et al. RNAi-mediated silencing of MLL-AF9 reveals leukemia-associated downstream targets and processes. Mol Canc. 2014;13:27–41.
   PubMed Web of Science ®Google Scholar
• Somervaille TCP, Clearly ML. Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Canc Cell. 2006;10:257–268.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676.
   PubMed Web of Science ®Google Scholar
• Aasen T. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol. 2008;26:1276–1284.
   PubMed Web of Science ®Google Scholar
• Haase A, Olmer R, Schwanke K, et al. Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell. 2009;5:434–441.
   PubMed Web of Science ®Google Scholar
• Yamasaki S, Taguchi Y, Shimamoto A, et al. Generation of human induced pluripotent stem (iPS) cells in serum and feeder-free defined culture and TGF-ß1 regulation of pluripotency. PLoS One. 2014;9:e93242.
   Web of Science ®Google Scholar
• Kim J, Hoffman JP, Alpaugh RK, et al. An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression. Cell Rep. 2013;3:2088–2099.
   PubMed Web of Science ®Google Scholar
• Tsuchiya S, Yamabe M, Yamaguchi Y, et al. Establishment and characterization of a human acute monocyte leukemia cell line (THP-1). Int J Cancer. 1980;26:171–176.
   PubMed Web of Science ®Google Scholar
• Swift S, Lorens J, Achacoso P, et al. Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. In: Coligan JE, Kruisbeek AM, Margulies DH, editors. Current protocols in immunology. Vol 1. 17C. New York: Wiley; 1999. pp. 1–17.
   Google Scholar
• Berggren WT, Lutz M, Modesto V. General spinfection protocol. In: StemBook, editor. The stem cell research community. California: StemBook; 2012. pp. 1–3.
   Google Scholar
• Yoshida Y, Takahashi K, Okita K, et al. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell. 2009;5:237–241.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861–872.
   PubMed Web of Science ®Google Scholar
• Zhang X, Cruz FD, Terry M, et al. Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency-based reprogramming. Oncogene. 2012;2012:1–12.
   Web of Science ®Google Scholar
• Davey FR, Erber WN, Gatter KC, et al. Immunophenotyping of acute myeloid leukemia by immunoalkaline phosphatase (APAAP) labeling with a panel of antibodies. Am J Hematol. 1987;26:157–166.
   PubMed Web of Science ®Google Scholar
• Ratei R, Karawajew L, Schabath R, et al. Differential expression of the carcinoembryonic antigen-related cell adhesion molecules panCD66, CD66a, CD66c and of sialyl-Lewis x (CD15s) on blast cells of acute leukemias. Int J Hematol. 2008;87:137–143.
   PubMed Web of Science ®Google Scholar
• Pession A, Martino V, Tonelli R, et al. MLL-AF9 oncogene expression affects cell growth but not terminal differentiation and is downregulated during monocyte–macrophage maturation in THP-1 cells. Oncogene. 2003;22:8671–8676.
   PubMed Web of Science ®Google Scholar
• Hass R, Kasper C, Böhm S, et al. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal. 2011;9:12–25.
   PubMed Web of Science ®Google Scholar
• Krampera M, Franchini M, Pizzolo G, et al. Mesenchymal stem cells: from biology to clinical use. Blood Transfus. 2007;5:120–129.
   PubMedGoogle Scholar
• Masui S, Nakatake Y, Toyooka Y, et al. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol. 2007;9:625–635.
   PubMed Web of Science ®Google Scholar
• Wang J, Levasseur DN, Orkin SH. Requirement of Nanog dimerization for stem cell self-renewal and pluripotency. Proc Natl Acad Sci USA. 2008;105:6326–6331.
   PubMed Web of Science ®Google Scholar
• Pranke P, Failace RR, Allebrandt WF, et al. Hematologic and immunophenotypic characterization of human umbilical cord blood. Acta Haematol. 2001;105:71–76.
   PubMed Web of Science ®Google Scholar
• Gadhoum SZ, Sackstein R. CD15 expression in human myeloid cell differentiation is regulated by sialidase activity. Nat Chem Biol. 2008;4:751–757.
   PubMed Web of Science ®Google Scholar
• Yamanaka S. Induced pluripotent stem cells: past, present, and future. Cell Stem Cell. 2012;10:678–684.
   PubMed Web of Science ®Google Scholar
• Cohen DE, Melton D. Turning straw into gold: directing cell fate for regenerative medicine. Nat Rev Genet. 2011;12:243–252.
   PubMed Web of Science ®Google Scholar
• Cahan P, Daley GQ. Origins and implications of pluripotent stem cell variability and heterogeneity. Nat Rev Mol Cell Biol. 2013;14:357–368.
   PubMed Web of Science ®Google Scholar
• Kumano K, Arai S, Hosoi M, et al. Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples. Blood. 2012;119:6234–6242.
   PubMed Web of Science ®Google Scholar
• Miyoshi N, Ishii H, Nagai K, et al. Defined factors induce reprogramming of gastrointestinal cancer cells. Proc Natl Acad Sci USA. 2010;107:40–45.
   PubMed Web of Science ®Google Scholar
• Mahalingam D, Kong CM, Lai J, et al. Reversal of aberrant cancer methylome and transcriptome upon direct reprogramming of lung cancer cells. Sci Rep. 2012;2:592–599.
   PubMed Web of Science ®Google Scholar
• O’Hagan RC, Heyer J. KRAS mouse models: modeling cancer harboring KRAS mutations. Gene Canc. 2011;2:335–343.
   PubMedGoogle Scholar
• Ng W. Mouse xenograft models for elucidating drug resistance mechanisms. PeerJ PrePrints. 2015;3:e1959.
   Google Scholar